Biotech Stock News (ATHX) (FLXN)

Athersys (NASDAQ:ATHX) In after-hours trade on February 18, 2016 shares of Athersys were up 21% after the company announced that it had obtained positive phase 2 results for its stroke trial. The phase 2 trial was broken down into two different parts. The first part was a dose selection phase of 16 patients split into … Read more

Athersys (ATHX) Stock | Why Poor Earnings Aren’t Concerning

Athersys, Inc. (NASDAQ: ATHX) As expected Athersys recently reported their earnings for the first quarter. Unfortunately, the report wasn’t what we expected to see. As a result, we saw a steep decline in the value of the stock earlier this morning, followed by a correction that brought the value back up. So today, we’ll talk … Read more

Biotech Stock News (ARWR)(AMGN)(ATHX)(PFE)

Arrowhead Research Corp (NASDAQ:ARWR) On April 13, 2015 Arrowhead announced that it was given the go-ahead by the FDA to begin treating patients in the phase 2b Hepatitis B study. ┬áThe drug compound being used in the study is known as ARC-520 which is an RNAi drug. RNAi stands for RNA interference and these types … Read more

Athersys (ATHX) Struggles With Merck & Co. (MRK) Superiority

Athersys, Inc. (NASDAQ: ATHX) On Friday, ATHX fell hard after releasing phase II study of MultiStem cell therapy for treatment of ischemic stroke data. The data showed that the treatment missed both primary and secondary end points; providing absolutely no benefit after 90 when compared to a placebo. As a result, the stock fell to … Read more

Athersys (ATHX) Stock Declines Ahead Of Results

Athersys, Inc. (NASDAQ: ATHX) Athersys has a big day coming on the 19th. As mentioned in a previous post, the company will be releasing the results of the last clinical trial for their MultiStem treatment. The treatment is expected to help patients recover from stroke more quickly. However, it doesn’t seem as though investors are … Read more

Athersys (ATHX) Stock | April 19th Will Be A Big Day

Athersys, Inc. (NASDAQ: ATHX) Athersys, Inc. stock recently climbed following an announcement that they would provide Phase 2 data from a new treatment on April 19th at the European Stroke Organization Conference. After the climb, the stock started to reach resistance as investors started to think about what the presentation means. In all reality, on … Read more

Why Stocks Are Falling So Hard Today

US stocks are down overall today for the third day in a row today; with today’s drop looking to be the steepest for many. Before the closing bell today, it was announced that orders for durable goods fell dramatically in the month of February; marking the third month out of the last four that we’ve … Read more